dMed Competitors and Similar CompaniesClear all

Apeloa Pharmaceutical's competitors and similar companies include Karyopharm Therapeutics.
Apeloa Pharmaceutical
Apeloa Pharmaceutical
Apeloa Pharmaceutical (普洛药业股份有限公司) is a company that develops and produces pharmaceutical products.
Karyopharm Therapeutics
Karyopharm Therapeutics
Karyopharm Therapeutics is a commercial-stage pharmaceutical company that pioneers in cancer therapies.
Founding Date
Founding Date
1989
Founding Date
2008
Type
Type
Public
Type
Public
Tags
Locations
Locations
CN HQ
Locations
Newton, US HQ
Givatayim, IL
Employees
Employees
7,060
Employees
22818% decrease
Valuation ($)
Valuation ($)
2.7 b
Valuation ($)
111.7 m

Financial

Revenue (est.)
Revenue (est.)
¥9.7b (FY, 2025)
Revenue (est.)
$146.1m (FY, 2025)
Cost of goods
Cost of goods
¥7.2b (FY, 2025)
Cost of goods
$5.9m (FY, 2025)
Gross profit
Gross profit
¥2.5b (FY, 2025)
Gross profit
$140.1m (FY, 2025)
Net income
Net income
¥890.7m (FY, 2025)
Net income
($196m) (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

Karyopharm Therapeutics
HQ
Newton, US
Employees
228↓ 18% decrease

Karyopharm Therapeutics is a commercial-stage pharmaceutical company that pioneers in cancer therapies.

View company